Urotoday - Advanced Prostate Cancer Treatment Center
Chemotherapy
- Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: The SPARC trial - Abstract
Friday, 30 October 2009
- IPF 2009 - Treatment of metastatic prostate cancer: New strategies - Session Highlights
Monday, 26 October 2009
- Novel targeted therapeutics for metastatic castration-resistant prostate cancer - Abstract
Friday, 02 October 2009
- PSA surge/flare-up in patients with castration-refractory prostate cancer during the initial phase of chemotherapy - Abstract
Wednesday, 16 September 2009
- A phase II trial of calcitriol and naproxen in recurrent prostate cancer - Abstract
Friday, 11 September 2009
- Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials - Abstract
Tuesday, 01 September 2009
- Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy - Abstract
Monday, 31 August 2009
- A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67 - Abstract
Tuesday, 18 August 2009
- Evaluation of docetaxel plus estramustine in the treatment of patients with hormone-refractory prostate cancer - Abstract
Tuesday, 18 August 2009
- Phase II study of Vinorelbine and Estramustine in combination with conformational radiotherapy for patients with high-risk prostate cancer - Abstract
Friday, 07 August 2009
- Survival after cytotoxic chemotherapy in patients with advanced hormone-resistant prostate cancer: A phase II study - Abstract
Tuesday, 04 August 2009
- Patients with Metastatic Hormone-Refractory Prostate Cancer : Second-Line Chemotherapy with Mitoxantrone Plus Prednisone - Abstract
Thursday, 16 July 2009
- Phase II Trial of Capecitabine and Weekly Docetaxel for Metastatic Castrate Resistant Prostate Cancer - Abstract
Tuesday, 30 June 2009
- Phase I Study of Concurrent Weekly Docetaxel and Repeated Samarium-153 Lexidronam in Patients With Castration-Resistant Metastatic Prostate Cancer - Abstract
Monday, 22 June 2009
- Paclitaxel, Estramustine and Carboplatin Combination Chemotherapy After Initial Docetaxel-Based Chemotherapy in Castration-Resistant Prostate Cancer - Abstract
Monday, 22 June 2009
- A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel/Prednisolone in Patients with Hormone-Refractory Prostate Cancer - Abstract
Wednesday, 17 June 2009
- Intermittent Docetaxel Therapy with Estramustine for Hormone-Refractory Prostate Cancer in Japanese Patients - Abstract
Monday, 08 June 2009
- ASCO 2009 - Five-Year Relapse-Free Survival and Predictors of Relapse Following Preoperative Docetaxel and Mitoxantrone for High-Risk Localized Prostate Cancer - Session Highlights
Tuesday, 02 June 2009
- ASCO 2009 - Ixabepilone, Mitoxantrone, and Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer Refractory to Docetaxel-Based Therapy: A Phase II Study of the DOD Prostate Cancer Clinical Trials Consortium - Session Highlights
Monday, 01 June 2009
- ASCO 2009 - A Phase II Study of Neoadjuvant Chemotherapy with Docetaxel and Bevacizumab in Patients with High-risk Localized Prostate Cancer: A Prostate Cancer Clinical Trials Consortium Trial - Session Highlights
Monday, 01 June 2009
- ASCO 2009 - Mature Results of a Randomized Phase II Study of OGX-011 in Combination with Docetaxel/Prednisone Versus Docetaxel/Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer - Session Highlights
Monday, 01 June 2009
- Characterization of Choline Uptake in Prostate Cancer Cells Following Bicalutamide and Docetaxel Treatment - Abstract
Monday, 18 May 2009
- Phase I Study of Ixabepilone, Mitoxantrone, and Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy: A Study of the Department of Defense Prostate Cancer Clinical Trials Consortium - Abstract
Thursday, 14 May 2009
- Combination Chemotherapy with Docetaxel, Vinorelbine and Estramustine Phosphate in Metastatic Androgen-Resistant Prostate Cancer: A Single Institution Experience - Abstract
Tuesday, 05 May 2009
- AUA 2009 - Emerging Therapies/Clinical Trials in Urology Oncology: Anti-Clusterin Therapy for Hormone Refractory Disease - SUO Meeting - Session Highlights
Saturday, 25 April 2009
- Docetaxel Plus Oblimersen Sodium (Bcl-2 Antisense Oligonucleotide): An EORTC Multicenter, Randomized Phase II Study in Patients with Castration-Resistant Prostate Cancer - Abstract
Monday, 20 April 2009
- Editorial - Synergy Between Anti-CCL2 and Docetaxel as Determined by DW-MRI in a Metastatic Bone Cancer Model
Thursday, 16 April 2009
- Phase II Trial of Neoadjuvant Nab-Paclitaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy - Abstract
Thursday, 19 March 2009
- Use of 5alpha-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline
Tuesday, 17 March 2009
- Oral Fenretinide in Biochemically Recurrent Prostate Cancer: A California Cancer Consortium Phase II Trial
Monday, 16 March 2009
- What is the Real Impact of Bone Pain on Survival in Patients with Metastatic Hormone-Refractory Prostate Cancer Treated with Docetaxel? - Abstract
Thursday, 12 March 2009
- Predictors of Response to Sildenafil Citrate Following Radiation Therapy for Prostate Cancer
Wednesday, 11 March 2009
- FOCUS on FOCIS: Combined Chemo-Immunotherapy for the Treatment of Hormone-Refractory Metastatic Prostate Cancer
Tuesday, 10 March 2009
- Regulation of Growth Factors in Hormone- and Drug-Resistant Prostate Cancer Cells by Synergistic Combination of Docetaxel and Octreotide
Thursday, 05 March 2009
- Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
Wednesday, 04 March 2009
- Somatostatin Analog Lanreotide in the Treatment of Castration-Resistant Prostate Cancer (CRPC)
Tuesday, 03 March 2009
- Beyond the Abstract - A 1-Year, Open Label, Randomized Phase II Dose Finding Study of Degarelix for the Treatment of Prostate Cancer in North America
Monday, 02 March 2009
- Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer
Wednesday, 25 February 2009
- In vitro and In vivo Anticancer Effects of the Novel Vitamin E Ether Analogue RRR- α - Tocopheryloxybutyl Sulfonic Acid in Prostate Cancer
Wednesday, 25 February 2009
- Chemotherapeutic Sensitization by Endoplasmic Reticulum Stress: Increasing the Efficacy of Taxane Against Prostate Cancer
Tuesday, 24 February 2009
- Combining Carboplatin and Etoposide in Docetaxel-Pretreated Patients with Castration-Resistant Prostate Cancer: A Prospective Study Evaluating Also Neuroendocrine Features
Monday, 23 February 2009
- Final Analysis of a Phase II Trial Using Sorafenib for Metastatic Castration-Resistant Prostate Cancer
Wednesday, 11 February 2009
- Algeta to Enroll US Patients Into Global Phase III ALSYMPCA Trial Following Successful End-of-Phase II Meeting With FDA
Wednesday, 04 February 2009
- Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent Apoptosis
Tuesday, 03 February 2009
-
Phase II Trial of Estramustine Phosphate and Oral Etoposide in Patients with Hormone-Refractory Prostate Cancer
Friday, 30 January 2009
- Beyond the Abstract - Finasteride for Prostatic Disease: An Updated and Comprehensive Review
Tuesday, 27 January 2009
- Hollis-Eden Researchers Present New Findings on Mechanism of Action for Anti-Cancer Drug Candidate APOPTONE™ (HE3235) at American Association of Cancer Research Meeting
Monday, 26 January 2009
- Phase II Trial of Neoadjuvant Docetaxel and Gefitinib Followed by Radical Prostatectomy in Patients With High-Risk, Locally Advanced Prostate Cancer
Tuesday, 20 January 2009
- Pharmacological Values of Medicinal Mushrooms for Prostate Cancer Therapy: The Case of Ganoderma Lucidum
Friday, 09 January 2009
- The Role of Systemic Cytotoxic Therapy for Prostate Cancer
Monday, 05 January 2009
- FDA Approves Ferring Pharmaceuticals' Degarelix (generic name) for Treatment of Advanced Prostate Cancer
Monday, 29 December 2008
- Low Dose Combinations of 2-Methoxyestradiol and Docetaxel Block Prostate Cancer Cells in Mitosis and Increase Apoptosis
Thursday, 18 December 2008
- Finasteride for Prostatic Disease: An Updated and Comprehensive Review
Tuesday, 16 December 2008
- The Role of Systemic Cytotoxic Therapy for Prostate Cancer
Tuesday, 16 December 2008
- The Efficacy and Safety of Degarelix: A 12-Month, Comparative, Randomized, Open-Label, Parallel-Group Phase III Study in Patients with Prostate Cancer
Friday, 12 December 2008
- OGX-011 Shows Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
Thursday, 04 December 2008
- Phthoxazolin A Inhibits Prostate Cancer Growth by Modulating Tumor-Stromal Cell Interactions
Monday, 01 December 2008
- Change in Markers of Bone Metabolism with Chemotherapy for Advanced Prostate Cancer: Interleukin-6 Response Is a Potential Early Indicator of Response to Therapy
Friday, 28 November 2008
- Targeted Delivery of Cisplatin to Prostate Cancer Cells by Aptamer Functionalized Pt(IV) Prodrug-PLGA-PEG Nanoparticles
Friday, 28 November 2008
- Abiraterone Acetate and Prednisone in Patients (Pts) with Progressive Metastatic Castration Resistant Prostate Cancer (CRPC) After Failure of Docetaxel-Based Chemotherapy
Wednesday, 13 August 2008
- Dasatinib in Patients with Hormone-Refractory Progressive Prostate Cancer: A Phase II Study
Wednesday, 13 August 2008
- Docetaxel (D) Plus Prednisone (P) in Combination with Metronomic Cyclophosphamide (CTX) and Celecoxib (C) as First Line Chemotherapy in Metastatic Hormone Refractory Prostate Cancer (HRPC): Phase II Clinical Trial with Pharmacodynamic Evaluation
Wednesday, 13 August 2008
- Current Status of Cytotoxic Chemotherapy in Patients with Metastatic Prostate Cancer
Wednesday, 09 July 2008
- Platelet Microparticles: A Potential Predictive Factor of Survival in Hormone-Refractory Prostate Cancer Patients Treated with Docetaxel-Based Chemotherapy
Friday, 04 July 2008
- Antitumour Effect of Electrochemotherapy with Bleomycin on Human Prostate Cancer Xenograft
Friday, 20 June 2008
- Beyond the Abstract - The Combination of Docetaxel and the Somatostatin Analogue Lanreotide on Androgen-Independent Docetaxel-Resistant Prostate Cancer: Experimental Data
Tuesday, 10 June 2008
- Chemotherapy in Hormone-Refractory Prostate Cancer
Wednesday, 09 April 2008
- Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue
Monday, 07 April 2008
- Pilot Trial of Adjuvant Paclitaxel Plus Estramustine in Resected High-Risk Prostate Cancer
Wednesday, 05 March 2008
- Combination of Bevacizumab and Docetaxel in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer: A Phase 2 Study
Monday, 03 March 2008
- Neoadjuvant Docetaxel and Capecitabine in Patients With High Risk Prostate Cancer
Friday, 29 February 2008
- ASCO GU 2008 - Impact of the Specific Endothelin A Receptor Antagonist ZD4054 on Overall Survival and Bone Metastasis in Patients with Hormone-Resistant Prostate Cancer: Results of a Phase II Trial
Saturday, 16 February 2008
- ASCO GU 2008 - Management of Post-Docetaxel Treatment
Saturday, 16 February 2008
- Equivalent and Sufficient Effects of Leuprolide Acetate and Goserelin Acetate to Suppress Serum Testosterone Levels in Patients With Prostate Cancer
Wednesday, 13 February 2008
- WUF 2008 - Serum PSA in Guiding Therapy for Men on Androgen Deprivation Therapy and for Men with Hormone Refractory Prostate Cancer
dSaturday, 02 February 2008
- Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study
Thursday, 17 January 2008
- Beyond the Abstract - Gonadotropin-Releasing Hormone Agonist-Induced Pituitary Apoplexy in Treatment of Prostate Cancer: Case Report and Review of Literature
Wednesday, 05 December 2007
- SUO 2007 - Prostate Cancer III: “New Options for Hormone Refractory Disease”
Monday, 03 December 2007
- Survival in Men with Nonmetastatic Prostate Cancer Treated with Hormone Therapy: A Quantitative Systematic Review
Friday, 30 November 2007
- Chemotherapy for the Treatment of Hormone-Refractory Prostate Cancer
Wednesday, 21 November 2007
- Weekly Administration of Docetaxel in Combination with Estramustine and Celecoxib in Patients with Advanced Hormone-Refractory Prostate Cancer: Final Results from a Phase II Study
Tuesday, 20 November 2007
- The Radiation Response of Hormone-Resistant Prostate Cancer Induced by Long-Term Hormone Therapy
Thursday, 01 November 2007
- SIU 2007 POD [04.06] - Hedgehog Signaling in Advanced Prostate Cancer
Monday, 03 September 2007
- SIU 2007 POD [04.02] - The Percentage of Positive Biopsies Is an Independent Predictor of Survival at the Onset of Hormonal Treatment for Advanced Prostate Cancer
Monday, 03 September 2007
- Luteinising Hormone-Releasing Hormone Antagonists in Prostate Cancer Therapy - Abstract
Monday, 03 September 2007
- Docetaxel and Cisplatin in Patients with Metastatic Androgen Independent Prostate Cancer and Circulating Neuroendocrine Markers
Wednesday, 29 August 2007
- Impact of PSA Flare-up in Patients with Hormone-Refractory Prostate Cancer Undergoing Chemotherapy - Abstract
Wednesday, 22 August 2007
- Docetaxel, Low-Dose Estramustine, and Doxifluridine in Hormone-Refractory Metastatic Prostate Cancer - Abstract
August 21, 2007
- New Paradigms for Advanced Prostate Cancer - Abstract
August 20, 2007
- Neoadjuvant Docetaxel Treatment for Locally Advanced Prostate Cancer: a Clinicopathologic Study
Tuesday, 07 August 2007
- Adjuvant Weekly Docetaxel for Patients with High Risk Prostate Cancer After Radical Prostatectomy: A Multi-Institutional Pilot Study
Friday, 11 May 2007
- Advanced Prostate Cancer - Comparative Reviews of the Major Guidelines
Thursday, 12 April 2007
- Weekly Docetaxel and Prednisolone versus Prednisolone Alone in Androgen-Independent Prostate Cancer: A Randomized Phase II Study
Friday, 02 March 2007
- European Urology - Current Indications for Chemotherapy in Prostate Cancer Patients
Monday, 01 January 2007
- European Urology - Looking Back at PCPT: Looking Forward to New Paradigms in Prostate Cancer Screening and Prevention
Monday, 01 January 2007
- Survey Reveals Physician Misconceptions of Combined Hormonal Therapy for Advanced Prostate Cancer
Wednesday, 01 November 2006
- Dendreon Announces New Data Analysis Presented at Chemotherapy Foundation Symposium
Friday, 10 November 2006
- Debate: What is the Optimum Timing of Systemic Therapy in Conjunction with Radical Prostatectomy for Locally Advanced Disease?
Saturday, 02 December 2006
- European Urology - Update on Phosphodiesterase (PDE) Isoenzymes as Pharmacologic Targets in Urology: Present and Future
Thursday, 23 November 2006
- European Urology - Management of the Spectrum of Hormone Refractory Prostate Cancer
Wednesday, 20 September 2006
- URS 2006 - Effects of a New Oncolytic Adenovirus (Xvir03) in Human Prostate Cancer Cell Lines and in a Xenograft Mouse Model
Sunday, 10 September 2006
- Few Well Performed Studies Address Management Of Lymph Node Positive Prostate Cancer
Monday, 26 June 2006
- ASCO 2006 - GU Oral Presentation: Prostate Cancer
Wednesday, 07 June 2006
- ASCO 2006 - GU Prostate Cancer Abstracts
Tuesday, 06 June 2006
- Phase I Study Combining Gefitinib With Docetaxel And Estramustine Reported
Thursday, 15 June 2006
- AUA 2006 - Prostate Cancer Targeted Therapy With Antisense Oligonucleotides
Sunday, 21 May 2006
- AUA 2006 - Prostate Cancer Localized III Session
Wednesday, 24 May 2006
- AUA 2006 - High-Risk Prostate Cancer Presented by Dr. Benson
Wednesday, 24 May 2006
- EAU 2006 - ABST [289] Second-line chemotherapy with docetaxel for prostate-specific antigen (PSA) relapse in men with hormone-refractory prostate cancer (HRPC) previously treated with docetaxel-based chemotherapy
Monday, 10 April 2006
- EAU 2006 - ABST [288] A phase II clinical study of high-dose Calcitriol plus Docetaxel and Zoledronic acid in hormone-refractory prostate cancer (HRPC)
Monday, 10 April 2006
- Progen Expand PI-88 Clinical Development To Prostate Cancer
Tuesday, 09 August 2005
- Cell Genesys Initiates Second Phase 3 Clinical Trial Of GVAX® Vaccine For Prostate Cancer
Tuesday, 05 July 2005
- Using PET Scan Technology to Measure Treatment Response In Metastatic Prostate Cancer
Monday, 13 June 2005
- EAU 2005 - ABST[568] Phase 2 Protocol with Docetaxel Plus Prednisone in Patients with Hormone Refractory Prostate Cancer
Thursday, 09 June 2005
- EAU 2005 - ABST[981] PSA-Flare up in Docetaxel Therapy of HRPC: Incidence and Clinical Impact?
Thursday, 09 June 2005
- EAU 2005 - ABST[993] Weekly Docetaxel, Zoledronic Acid, and Estramustine in Metastatic Androgen-Independent Prostate Cancer (MAIP)
Thursday, 09 June 2005
- EAU 2005 - ABST[570] Docetaxel, Estramustine and Prednisone for the Treatment of Hormone Refractory Prostate Cancer: A Single Center Experience
Thursday, 09 June 2005
- Genitinib and Docetaxel in Combination Therapy for Bladder Cancer, May 23, 2005
Monday, 23 May 2005
- Docetaxel-Containing Regimens Improve Survival in Advanced Prostate Cancer
Thursday, 07 October 2004
- Docetaxel Improves Survival in Hormone-Refractory Prostate Cancer
Thursday, 10 June 2004
- Taxotere Can Increase Survival in Prostate Cancer Patients
Tuesday, 08 June 2004
- Plenary Session: Docetaxel-based Chemotherapy in Hormone Refractory Prostate Cancer
Monday, 07 June 2004
- Plenary Session: Docetaxel-based Chemotherapy in Hormone Refractory Prostate Cancer
Monday, 07 June 2004
- New Cancer Strides to Be Unveiled at Big Meeting
Thursday, 03 June 2004
- Two Landmark Studies of Taxotere� in Prostate Cancer Highlighted in American Society of Clinical Oncology Plenary Session
Monday, 31 May 2004
- Aberalix Helpful in Some Advanced Prostate Cancer Patients
Tuesday, 11 May 2004
- Society of Urologic Oncology Annual Meeting
Saturday, 08 May 2004
Please log-in or register in order to submit comments. Powered by AkoComment! |
Prostate Cancer 
